Matches in Nanopublications for { ?s ?p "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP773487.RAhkm5W-K1cu58WJd2xq0Y7-oDRowHEjP9gathBoCABks130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773487.RAhkm5W-K1cu58WJd2xq0Y7-oDRowHEjP9gathBoCABks130_provenance.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_provenance.
- NP873036.RAY26P7tqAYKuo_UtOLGRRacNioLDRke_8eBZbCpSyizI130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873036.RAY26P7tqAYKuo_UtOLGRRacNioLDRke_8eBZbCpSyizI130_provenance.
- assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP347315.RADKfuuZd_YHo2BlP_eMasDeERnn-6ZIfmBg8LhMziorg130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347315.RADKfuuZd_YHo2BlP_eMasDeERnn-6ZIfmBg8LhMziorg130_provenance.
- NP555435.RAhJqswnFew4WT-Idf5t2Jd0eMBiZB3s--4H3udXbi4SE130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555435.RAhJqswnFew4WT-Idf5t2Jd0eMBiZB3s--4H3udXbi4SE130_provenance.
- NP839108.RAPBuaLNwlQqWJYOomsR4ObX8XTKxjoAAjp-Ii4nBtVIY130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839108.RAPBuaLNwlQqWJYOomsR4ObX8XTKxjoAAjp-Ii4nBtVIY130_provenance.
- NP586091.RAfA5FwQkeCKWS2F09Ys3AT5Vhj4Izb_Q2wcPjpfFn2dA130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586091.RAfA5FwQkeCKWS2F09Ys3AT5Vhj4Izb_Q2wcPjpfFn2dA130_provenance.
- NP555323.RAw8UwyEkr9yMXPPAvC2DaLadF235QwrTwjJ3VVJWhsNU130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555323.RAw8UwyEkr9yMXPPAvC2DaLadF235QwrTwjJ3VVJWhsNU130_provenance.
- NP586089.RAKst5Yqfc4xd_yCJOSscXYdDlHYG_sx0HVsm-qsberSQ130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586089.RAKst5Yqfc4xd_yCJOSscXYdDlHYG_sx0HVsm-qsberSQ130_provenance.
- NP586090.RAN1c1KwXb7ugkp747ddCdLMZeffFiUbL5JcMHfhKqINY130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586090.RAN1c1KwXb7ugkp747ddCdLMZeffFiUbL5JcMHfhKqINY130_provenance.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_provenance.
- NP586085.RAwHdCGqwVvhxq5G0JXKMs9eTOe-WQpahHta_pX2-58MI130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586085.RAwHdCGqwVvhxq5G0JXKMs9eTOe-WQpahHta_pX2-58MI130_provenance.